CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,514,898 | +4.9% | 899,478 | +20.6% | 0.01% | 0.0% |
| Q2 2023 | $10,023,297 | -25.6% | 745,781 | -8.2% | 0.01% | -27.3% |
| Q1 2023 | $13,466,375 | -13.8% | 812,206 | -3.3% | 0.01% | -15.4% |
| Q4 2022 | $15,629,599 | +60.3% | 840,301 | +10.5% | 0.01% | +44.4% |
| Q3 2022 | $9,753,000 | +120.2% | 760,174 | +20.3% | 0.01% | +125.0% |
| Q2 2022 | $4,430,000 | +54.7% | 631,904 | +83.0% | 0.00% | +100.0% |
| Q1 2022 | $2,863,000 | +91.9% | 345,348 | +56.7% | 0.00% | +100.0% |
| Q4 2021 | $1,492,000 | +68.6% | 220,424 | +32.0% | 0.00% | 0.0% |
| Q3 2021 | $885,000 | +79.9% | 167,041 | +95.3% | 0.00% | – |
| Q2 2021 | $492,000 | +151.0% | 85,544 | +101.6% | 0.00% | – |
| Q1 2021 | $196,000 | +56.8% | 42,430 | +13.5% | 0.00% | – |
| Q4 2020 | $125,000 | +20.2% | 37,399 | +7.3% | 0.00% | – |
| Q3 2020 | $104,000 | +19.5% | 34,866 | +86.0% | 0.00% | – |
| Q2 2020 | $87,000 | – | 18,747 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |